Impact of Storage Conditions on a New Child-Friendly Dispersible Tablet for Treating Tuberculosis in Pediatrics
Background: In 2020 the composition and procedure to elaborate a new formulation containing Isoniazid, Pyrazinamide and Rifampicin to treat tuberculosis in pediatric patients was published. The temperature and relative humidity in Tuberculosis-endemic countries are high, > 30 ºC and > 70% resp...
Saved in:
Main Authors: | Javier Suárez González (Author), Ana Santoveña Estévez (Author), Mabel Soriano (Author), Jose Bruno Fariña (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics
by: Ana Santoveña-Estévez, et al.
Published: (2020) -
Tablet Disintegration and Dispersion under In Vivo-like Hydrodynamic Conditions
by: Jan Lenz, et al.
Published: (2022) -
Impacts of storage conditions on the dissolution performance of commercial metronidazole tablets available in Saudi Arabia
by: Basmah N. Aldosari, et al.
Published: (2024) -
Superdisintegrant Selection for Tramadol Dispersible Tablets
by: Swati C. Jagdale, et al.
Published: (2010) -
Characterization and Validation of a New 3D Printing Ink for Reducing Therapeutic Gap in Pediatrics through Individualized Medicines
by: Eduardo Díaz-Torres, et al.
Published: (2023)